Related Experiment Videos
Adherence and its management in clinical trials: implications for arthritis treatment trials
Insights
Ensuring participant adherence in clinical trials is crucial for reliable results. This review covers adherence principles, prevention strategies, and intervention plans for cardiovascular and arthritis trials.
Area of Science:
- Clinical Research
- Cardiovascular Diseases
- Rheumatology
Background:
- Participant adherence is a persistent challenge across all clinical trial types.
- Poor adherence can compromise the validity and reliability of clinical trial data.
- Cardiovascular and arthritis clinical trials provide relevant examples for adherence issues.
Purpose of the Study:
- To review fundamental principles of adherence in clinical trials.
- To present a comprehensive program for enhancing adherence in clinical trials.
- To detail prevention and intervention strategies for participant adherence.
Main Methods:
- Review of existing literature and data from cardiovascular clinical trials.
- Analysis of adherence challenges and solutions in arthritis clinical trials.
- Development of a framework for adherence management in clinical research.
Main Results:
- Adherence is critical for the integrity of clinical trial outcomes.
- A structured adherence program can mitigate participant non-compliance.
- Specific strategies are effective for both preventing reduced adherence and managing existing non-adherence.
Conclusions:
- Implementing robust adherence programs is essential for successful clinical trials.
- Proactive prevention and tailored interventions improve participant adherence.
- Understanding adherence dynamics is key to advancing medical research.
Abstract:
Adherence in clinical trials is a consistent problem regardless of the disease process or organ system under investigation. In this paper data and examples from clinical trials examining cardiovascular diseases are used as the basis for a review of various adherence principles. Issues reviewed include: the importance of adherence in clinical trials, an overall program for adherence in clinical trials, and specific issues in adherence from arthritis clinical trials. Special attention is given to a program for the prevention of reduced adherence for participants of a clinical trial as well as acute and chronic intervention plans for those with good adherence and those with reduced adherence in a clinical trial.